The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis

OBJECTIVE: Fibroblast growth factor 19 (FGF19) is a postprandial hormone which plays diverse roles in the regulation of bile acid, glucose, and lipid metabolism. Administration of FGF19 to obese/diabetic mice lowers body weight, improves insulin sensitivity, and enhances glycemic control. The primar...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonellis, Patrick J., Droz, Brian A., Cosgrove, Richard, O'Farrell, Libbey S., Coskun, Tamer, Perfield, James W., Bauer, Steven, Wade, Mark, Chouinard, Tara E., Brozinick, Joseph T., Adams, Andrew C., Samms, Ricardo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807368/
https://www.ncbi.nlm.nih.gov/pubmed/31767164
http://dx.doi.org/10.1016/j.molmet.2019.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807368/
https://www.ncbi.nlm.nih.gov/pubmed/31767164
http://dx.doi.org/10.1016/j.molmet.2019.09.006

Ejemplares similares